5 things to know about the FDA's flawed approach to accelerated drug approvals

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

Related Keywords

Robert Califf ,Ron Wyden ,Rachel Sherman ,Gregg Gonsalves ,Drug Administration ,Drug Evaluation ,Accelerated Approval Pathway ,